Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,340,252
+$329,557 QoQ
Shares Held
9,300
+0.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.73%
of 13F equity value
Holder Rank
#1,845
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HEADINVEST, LLC holds $15,409,722 across 8 Drug Manufacturers - General names. ABBV ranks #3 (15.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVO |
Novo Nordisk A S
|
88,590 | $4,247,004 | |
| 2 | NVS |
Novartis AG
|
15,391 | $2,412,077 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
9,300 | $2,340,252 | |
| 4 | LLY |
ELI LILLY & Co
|
1,634 | $1,959,868 | |
| 5 | MRK |
Merck & Co., Inc.
|
14,769 | $1,897,816 | |
| 6 | JNJ |
Johnson & Johnson
|
7,126 | $1,809,790 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
6,791 | $391,297 | |
| 8 | AMGN |
Amgen Inc
|
971 | $351,618 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,340,252 | 9,300 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,010,695 | 9,245 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,177,966 | 9,532 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $1,945,630 | 8,403 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,506,306 | 8,115 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,958,173 | 9,346 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,723,690 | 9,700 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $1,957,224 | 9,911 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $1,722,918 | 10,045 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,888,741 | 10,372 | Shares | Sole | 2024-08-14 | |
| 2023-12-31 | $1,674,760 | 10,807 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $1,725,667 | 11,577 | Shares | Sole | 2023-12-11 | |
| 2023-06-30 | $1,693,960 | 12,573 | Shares | Sole | 2023-08-23 | |
| 2023-03-31 | $2,167,910 | 13,603 | Shares | Sole | 2023-05-17 | |
| 2022-12-31 | $2,324,598 | 14,384 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,934,234 | 14,412 | Shares | Sole | 2022-12-28 | |
| 2022-06-30 | $2,196,161 | 14,339 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,330,817 | 14,378 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,926,742 | 14,230 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,495,078 | 13,860 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $1,547,448 | 13,738 | Shares | Sole | 2021-08-30 | |
| 2021-03-31 | $1,469,302 | 13,577 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,305,301 | 12,182 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $898,147 | 10,254 | Shares | Sole | 2020-11-24 | |
| 2020-06-30 | $896,285 | 9,129 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $667,424 | 8,760 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||